Fanconi anemia founder mutation in Macedonian patients

Acta Haematol. 2014;132(1):15-21. doi: 10.1159/000355191. Epub 2013 Dec 13.

Abstract

Background: Fanconi anemia (FA) is a rare autosomal recessive disorder clinically characterized by developmental abnormalities, progressive bone marrow failure (BMF) and profound cancer predisposition. Approximately 65% of all affected individuals have mutation in the FANCA (Fanconi anemia complementation group A) gene. The mutation spectrum of the FANCA gene is highly heterogeneous. FA-A is usually associated with private FANCA mutations in individual families.

Methods: We describe 3 unrelated patients with FA with a similar clinical presentation: BMF, renal anomalies and café-au-lait pigmentation without major skeletal abnormality. The molecular analysis of the FANCA gene using the FA MLPA kit P031-A2/P032 FANCA, showed homozygous deletion of exon 3 in all 3 patients. Molecular analysis of the flanking regions of exon 3 precisely defined unique deletion of 2,040 bp and duplication of C (1788_3828dupC).

Discussion/conclusions: These are the first 3 patients homozygous for deletion of FANCA exon 3 described to date. Although not related, the patients originated from the same Gypsy-like ethnic population. We conclude that c.190-256_283 + 1680del2040 dupC mutation in the FANCA gene is a founder mutation in Macedonian FA patients of Gypsy-like ethnic origin. Our finding has very strong implications for these patients in formulating diagnostic and carrier-screening strategy for BMF and FA and to enable comprehensive genetic counseling.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Child
  • DNA Mutational Analysis
  • Exons
  • Fanconi Anemia / genetics*
  • Fanconi Anemia Complementation Group A Protein / genetics*
  • Female
  • Founder Effect*
  • Homozygote
  • Humans
  • Male
  • Mutation*
  • Pedigree
  • Republic of North Macedonia
  • Roma / genetics
  • Sequence Deletion
  • Young Adult

Substances

  • FANCA protein, human
  • Fanconi Anemia Complementation Group A Protein